Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Carboplatin in Extensive Stage Small Cell Lung Cancer
NCT00227565Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in small cell lung cancer (SCLC), sponsored by Cancer and Leukemia Group B. Started Feb 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00227565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227565.